Does Nuvalent's Recent Trial Success Justify the Stock's 36% 2025 Rally? [Yahoo! Finance]
Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference
Nuvalent Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares from Selling Stockholders
Nuvalent (NASDAQ:NUVL) was given a new $140.00 price target on by analysts at Truist Financial Corporation.